Patents/Assignees

ZOMAGEN BIOSCIENCES Ltd

3 patents in portfolio

US12466800utility2025
N-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-4, 5, 6, 7-tetrahydrobenzofuran-2-sulfonamide Derivatives and Related Compounds as NLPR3 Modulators for the Treatment of Multiple Sclerosis (MS)
0 cites
US12351564utility2025
NLRP3 Modulators
0 cites
US11603375utility2023
NLRP3 Modulators
0 cites